Market Overview

Pertussis| A Drug Pipeline Analysis Report 2018| Technavio


Technavio has announced their latest pipeline analysis report on the pertussis
. The report includes a detailed analysis of the pipeline
molecules under investigation within the defined data collection period
to treat pertussis.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for pertussis, including a det ...

Technavio has published a new report on the drug development pipeline for pertussis, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Pertussis: Market overview

Pertussis is a highly contagious respiratory disease and is also known
as whooping cough. The Bordetella pertussis bacterium is the causing
agent of pertussis. When infected by pertussis, patients suffer from
uncontrollable, violent coughing, which often makes it difficult to
breathe. After coughing, someone with pertussis often needs to take deep
breaths, which results in a whooping sound. People of all ages can be
affected by pertussis, but it can be very serious, even deadly, for
infants aged less than 1 year. People with pertussis usually spread the
disease to another person by coughing or sneezing, or when spending a
lot of time near one another where they share the breathing space. Many
babies with pertussis are infected by older siblings, parents, or
caregivers, who are unaware that they have this disease.

According to a senior market research analyst at Technavio, "People
who are infected with pertussis are most contagious up to 2 weeks after
the cough begins. Antibiotics may shorten the amount of time someone is
contagious. Vaccination in the appropriate age and time is the best
treatment available for pertussis."

Pertussis: Segmentation analysis

This drug pipeline analysis report segments the pertussis market based
on therapies employed (monotherapy and combination therapy), RoA
(intramuscular, intranasal, subcutaneous, epicutaneous, and
intravenous), therapeutic modality (vaccine, antibody, and monoclonal
antibody), targets (pertussis toxin, Th17, FHA, and PNAG), MoA
(immunostimulant, anti-pertussis antibody formation, Th1 systemic
immunity, and PNAG inhibitor), geographical segmentation (APAC,
Americas, and EMEA) and recruitment status (active, not recruiting,
completed, not yet recruiting, and recruiting). It provides an in-depth
analysis of the prominent factors influencing the market, including
drivers, opportunities, trends, and industry-specific challenges.

Based on mechanism of action, around 69% of the molecules that are being
investigated for the treatment of pertussis are immunostimulant.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!